Choi JI, Freedman G, Guttman D, Ahmed K, Gao W, Walker E, Harris L, Gonzalez V, Ye J, Nead K, Taunk N, Tadros A, Dang C, Daroui P, Novick K Executive Summary of the American Radium Society (ARS) Appropriate Use Criteria (AUC): Regional Nodal Irradiation for Breast Cancer , American Journal of Clinical Oncology, 48(3): 2025
Berlin E, Ko K, Ma L, Messing I, Hollawell C, Smith AM, Taunk NK, Narayan V, Upshaw JN, Clark AS, Shah PD, Knollman H, Bhattacharya S, Koropeckyj-Cox D, Wang J, Yegya-Raman N, Han IS, Lefebvre B, Li T, Wilcox NS, Jung W, Chen J, Freedman GM, Ky B Cardiac Effects of Modern Breast Radiation Therapy in Patients Receiving Systemic Cancer Therapy , JACC: CardioOncology: 2025
Barrett M, Demissei BG, Hu R, Smith AM, Freedman G, Plastaras J, Feigenberg S, Berlin E, Narayan HK, Lefebvre B, Crosbie MS, Fradley M, Carver J, Chen J, Ky B 3D Echocardiographic Phenotyping of Left Ventricular Mechanics and Function With Contemporary Radiation Therapy , Adv Rad Onc: 2025
Cederquist GY, Boe LA, Walsh M, Freedman GM, Maxwell KN, Taunk N, Braunstein LZ Radiation-Associated Secondary Cancer in Patients With Breast Cancer Harboring TP53 Germline Variants , JAMA Oncology: 2024
Hahn EA, Pugh SL, Lu HL, Vela AM, Gillespie EF, Nichols EM, Wright JL, MacDonald SM, Cahlon O, Baas C, Braunstein LZ, Fang LC, Freedman GM, Jimenez RB, Kesslering CM, Mishra MV, Mutter RW, Ohri N, Rosen LR, Urbanic JJ, Jagsi R, Mitchell SA, Bekelman JE, Cella D; RadComp (Radiotherapy Comparative Effectiveness Consortium). Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial , Int J Radiat Oncol Biol Phys, 120: 2024,149-161
Iwai Y, Perez-Rojas S, Thomas SM, Tadros AB, Woodward SG, Zhang JQ, Elmore LC, Freedman GM, Tchou JC, Bleznak AD, Fayanju OM Guideline-Concordant Surgical Care for Lobular Versus Ductal Inflammatory Breast Cancer , Ann Surg Oncol: 2024
Freedman GM, Li T, Garver E, Shillington K, Shinkle B, Tchou JC, Fayanju OM, Lin L, Taunk NK Five-year outcomes of a phase I/II trial of accelerated partial breast irradiation using proton therapy for women with stage 0-IIA breast cancer , Advances in Radiation Oncology, 9(2): 2023
Manik R, Grady CB, Elmore LC, Fieber JH, Freedman GM, Jankowitz RC, Tchou JC, Zhang JQ, Hubbard RA, Fayanju OM Temporal Trends and Factors Associated with Receipt of Post-Mastectomy Radiation after Neoadjuvant Chemotherapy in Women with cT3 Breast Cancer , ASO: 2023
Berlin E, Yegya-Raman N, Hollawell C, Haertter A, Rhodes S, Seol S, Gentile M, Li T, Freedman GM, Taunk NK Breast Reconstruction Complications Following Post-Mastectomy Proton Radiotherapy for Breast Cancer , Advances in Radiation Oncology , 9(3): 2023
Jagsi R, Griffith KA, Harris EE, Wright JL, Recht A, Taghian AG, Lee L, Moran MS, Small Jr W, Johnstone C, Rahimi A, Freedman G, Muzaffar M, Haffty B, Horst K, Powell SN, Sharp J, Sabel M, Schott A, El-Tamer M Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA , J Clin Oncol: 2023
